Prilenia Therapeutics

formerly Prilenia

A Clinical Stage Biotech Company

Amsterdam, Netherlands · Founded 2018 · $115.5M raised

Headquarters
Amsterdam
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$115.5M
Last Round
$10.0M Series BJan 2022
Rounds
3

About

Prilenia Therapeutics B.V. is a clinical-stage biotechnology company focused on developing novel therapeutics to slow the progression of neurodegenerative diseases, including Huntington's disease and ALS. Its pipeline centers on pridopidine, which the company is advancing through clinical programs and a collaboration and license agreement with Ferrer for commercialization and co-development in Europe and other select markets. The company is led by CEO Dr. Michael Hayden, a Huntington's disease expert.

Summary

Prilenia Therapeutics is a Biotech company based in Amsterdam, Netherlands, founded in 2018. It has raised $115.5M in total across 3 rounds, most recently a $10.0M Series B round in Jan 2022. Investors include Forbion Capital Partners, Sands Capital and Sectoral Asset Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJan 2022
$10.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prilenia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/prilenia-therapeutics"><img src="https://indexed.vc/api/badge/company/prilenia-therapeutics" alt="Prilenia Therapeutics on Indexed.vc" width="260" height="76" /></a>